2022
DOI: 10.1093/fampra/cmac014
|View full text |Cite
|
Sign up to set email alerts
|

Varicella zoster virus reactivation following COVID-19 vaccination: a report of 3 cases

Abstract: Background The advent of vaccination against COVID-19 brought great expectations for the control of the pandemic. As novel vaccines, much of the associated side effects were unknown. Currently, an increasing number of reports from side effects of COVID-19 vaccines have been published, namely on cutaneous reactions. These are of utmost importance to increase our knowledge about possible undesirable effects and its prevention. Methods … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 19 publications
0
1
0
Order By: Relevance
“…There were several vaccines that caused reactivation: BNT162b2 mRNA or Pfizer–BioNTech ( n = 76), Oxford-AstraZeneca ( n = 22), mRNA-1273 or Moderna ( n = 17), Sinovac ( n = 4), BBIBP-CorV or Sinopharm ( n = 3), Covaxin ( n = 3), Covishield ( n = 3), and Johnson and Johnson ( n = 1). In some of the cases, the exact model of the vaccine was not reported in the paper [ 53 , 90 , 99 , 100 ]. Reactivated HHVs included varicella-zoster virus ( n = 114), cytomegalovirus ( n = 15), HSV-1 ( n = 14), Epstein-Barr virus ( n = 6), and HHV-6 ( n = 2).…”
Section: Resultsmentioning
confidence: 99%
“…There were several vaccines that caused reactivation: BNT162b2 mRNA or Pfizer–BioNTech ( n = 76), Oxford-AstraZeneca ( n = 22), mRNA-1273 or Moderna ( n = 17), Sinovac ( n = 4), BBIBP-CorV or Sinopharm ( n = 3), Covaxin ( n = 3), Covishield ( n = 3), and Johnson and Johnson ( n = 1). In some of the cases, the exact model of the vaccine was not reported in the paper [ 53 , 90 , 99 , 100 ]. Reactivated HHVs included varicella-zoster virus ( n = 114), cytomegalovirus ( n = 15), HSV-1 ( n = 14), Epstein-Barr virus ( n = 6), and HHV-6 ( n = 2).…”
Section: Resultsmentioning
confidence: 99%